(Q34727203)

4 August 2017

1 reference

title

Clinical cardiovascular studies of hormone replacement therapy (English)

1 reference

4 August 2017

1 reference

Peter Collins

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

90

1 reference

4 August 2017

issue

1A

1 reference

4 August 2017

page(s)

30F-34F

1 reference

Coronary heart disease: an older woman's major health risk

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

The protective effects of estrogen on the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Testosterone relaxes rabbit coronary arteries and aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Estrogen hits the surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Prospective randomized study of the effect of "add-back" hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Short-term estrogen administration ameliorates dobutamine-induced myocardial ischemia in postmenopausal women with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Oestrogen improves exercise-induced myocardial ischaemia in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Menopause and the risk of coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

The Women's Health Initiative: recruitment complete--looking back and looking forward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Design of the Women’s Health Initiative Clinical Trial and Observational Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

Oestrogen and women's heart disease: ESPRIT-UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2902220-2

10.1016/S0002-9149(01)02220-2

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference